Health Condition 1: null- Patients undergoing elbow or below elbow surgeries
Conditions
Interventions
Intervention1: Group SF: 20 ml of 2% lignocaine with 5mcg/cc AdrenalineI deposited inside the brachial plexus sheath under ultrasound guidance
Control Intervention1: Group EF: 20 ml of 2% lignocaine w
Sponsors
CIDRF
Department of Anaesthesiology
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1 and 2 and weighing 50-60kg patients undergoing elbow or below elbow surgeries
Exclusion criteria
Exclusion criteria: H/o any co-morbidities, coagulopathy, Local anaesthetic allergy, infection at the site of block, preexisting neurological deficit of the surgical limb
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peak Plasma ConcentrationTimepoint: Pre block (Baseline), 10, 20, 30, 45, 60, 90, 120 minutes post Brachial plexus block | — |
Secondary
| Measure | Time frame |
|---|---|
| Complete Motor BlockadeTimepoint: every 3 minutes for first 15 minutes and then every 5 minutes till scale 0 sensory and motor blockade or 40 minutes which ever earlier;Complete Sensory BlockadeTimepoint: every 3 minutes for first 15 minutes and then every 5 minutes till scale 0 sensory and motor blockade or 40 minutes which ever earlier;Duration of analgesiaTimepoint: 2, 4, 6, 24 post-operative hours from time 0 or till sensory level 2 and motor level 2 whichever earlier ;Time to Peak Plasma ConcentrationTimepoint: Pre block (Baseline), 10, 20, 30, 45, 60, 90, 120 minutes post Brachial plexus block | — |
Countries
India
Contacts
Public ContactJaya V
Mahatma Gandhi Medical College and Research Institute
Outcome results
None listed